Deals
UK wealth manager Mattioli Woods is to acquire lower-mid cap private equity house Maven Capital Partners.
The deal will allow Maven to leverage the Mattioli Woods partnership to access further capital to help boost growth and will also enhance Maven’s services and capability through access to Mattioli Woods’ advisor and client base as well as expertise in a broader range of products.
Separately Mattioli Woods is also acquiring Ludlow Wealth Management, one of the largest independent providers of investment, financial planning and pension advice in the North West of England.
There is a long-standing relationship between Maven senior management and
CORE Industrial Partners (CORE), a Chicago-based private equity firm, has acquired Marianna Beauty Holdings (Marianna), an Omaha, Nebraska-based leading developer and manufacturer of innovative hair, skin and beauty products, by portfolio company Arizona Natural Resources (ANR).
Founded in 1968, Marianna is a full-service custom manufacturer, formulator and distributor of client-tailored hair care, hand and body products, styling aids and fixatives, hair colour and dispensary products, and pet grooming products. Marianna operates a 400,000 square foot FDA-registered and cGMP-compliant facility, offering a comprehensive suite of capabilities, including research and development, packaging compatibility, preservative efficacy and micro testing, regulatory expertise, global sourcing
Frazier Healthcare Partners has closed Frazier Healthcare Growth Buyout Fund X, its 10th healthcare private equity fund focused on the middle market, a vehicle which was oversubscribed and hit its USD1.4 billion hardcap.
The capital came in from new as well as existing limited partners, including public pension funds, financial institutions, foundations and endowments, family offices, corporate pensions and sovereign wealth funds from investors based in the US, Europe, the Middle East and Asia.
“Our three decades of focusing on the healthcare industry, breadth and depth of our ecosystem and team resonated with both new and existing investors,” comments Ben Magnano,
Financial services provider iBanFirst, which delivers solutions across banking borders, has secured a growth equity investment to fund product development, international expansion and M&A, from global private equity firm Marlin, which became the fintech’s largest shareholder as a result, replacing existing business angels and some of the company’s early backers.
Through the transaction, a number of iBanFirst’s historic partners, including top-tier venture capital firm Elaia, Bpifrance Large Venture and Xavier Niel, have strengthened their existing commitments. iBanFirst CEO and Founder, Pierre-Antoine Dusoulier, will become the company’s second-largest shareholder as part of the new agreement.
The move marks a shift
Varagon Capital Partners (Varagon) is serving as Administrative Agent, Joint Lead Arranger, Joint Bookrunner and Syndication Agent on a senior secured credit facility to support the acquisition of JTM Foods, LLC (JTM) by Tenex Capital Management (Tenex).
Headquartered in Erie, PA, JTM Foods, LLC, has been producing premium quality snack pies and other sweet treats since 1985.
The Company produces JJ’s Bakery branded, co-manufactured, and private label sweet baked goods such as fruit filled snack pies, mini pies, and crispy rice treats.
MediSpend, a global technology company providing solutions for the life sciences industry, has secured a majority investment from Susquehanna Growth Equity (SGE), an entrepreneur-centric growth equity firm exclusively focused on software and information services companies.
SGE’s prior investments across the broader healthcare vertical include Evive, HMP Global, iContracts, MMIT, ProviderTrust and RLDatix. Financial terms of the investment were not disclosed.
MediSpend provides solutions for the life sciences industry, enabling some of the world’s largest pharmaceutical, medical device and emerging biotech companies to compliantly manage high-risk business functions through top-rated software and client services. The MediSpend Global Compliance Suite represents
The Riverside Company, a global private investor focused on the smaller end of the middle market, has signed a definitive agreement to sell Greenphire, a specialist in financial lifecycle management software for clinical trials, to Thoma Bravo, a software focused private equity firm.
The pending transaction is expected to close in the second quarter of this year, subject to the satisfaction of regulatory approval and customary closing conditions. Financial details were not disclosed.
Founded in 2008, Greenphire enables pharmaceutical industry leaders worldwide to run more efficient and successful clinical trials. The company’s end-to-end solutions optimise clinical trial performance by streamlining
Medtanken, a leading primary care group in Western Sweden and a portfolio company of Procuritas Capital Investors VI (Procuritas), has successfully made its first step into the specialist care sector by acquiring Citysjukhuset.
With its passion for building strong sustainable businesses through transformational growth, Procuritas is facilitating accelerated development and multi-regional and digital expansion of the group. Today’s expansion follows last month’s news of Medtanken’s first bolt-on growth acquisition of Kvarterskliniken.
Medtanken has a vision of delivering and enhancing quality primary care provision in Sweden and today it also announces the successful launch of a new app offering a digi-physical
Novo Holdings has co-led with Vivo Capital the over-subscribed USD200 million Series A and Crossover round in Esco Lifesciences Group (Esco), a leading provider of life sciences tools and services.
A new venture investment business has been formed via a partnership between the city advisory group Forster Chase and four successful CEOs/entrepreneurs, designed to guide and turbo charge young companies through to highly valuable exits.
Forster Chase Ventures, in conjunction with the other companies in the group (Forster Chase Executive Search, Forster Chase Corporate Finance) will create significant value for founders and shareholders by delivering exceptional strategy, people, distribution and capital solutions. Given the cashflow challenges that young businesses often face, this will be a cost-effective model that is focused on long term mutual success and growth.
Over multiple years
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
